Kim_2022_Vascul.Pharmacol__107086

Reference

Title : Soluble epoxide hydrolase inhibitor, TPPU, attenuates progression of atherosclerotic lesions and vascular smooth muscle cell phenotypic switching - Kim_2022_Vascul.Pharmacol__107086
Author(s) : Kim SA , Lee AS , Lee HB , Hur HJ , Lee SH , Sung MJ
Ref : Vascul Pharmacol , :107086 , 2022
Abstract : Kim_2022_Vascul.Pharmacol__107086
ESTHER : Kim_2022_Vascul.Pharmacol__107086
PubMedSearch : Kim_2022_Vascul.Pharmacol__107086
PubMedID: 35752378

Related information

Citations formats

Kim SA, Lee AS, Lee HB, Hur HJ, Lee SH, Sung MJ (2022)
Soluble epoxide hydrolase inhibitor, TPPU, attenuates progression of atherosclerotic lesions and vascular smooth muscle cell phenotypic switching
Vascul Pharmacol :107086

Kim SA, Lee AS, Lee HB, Hur HJ, Lee SH, Sung MJ (2022)
Vascul Pharmacol :107086